Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhisa Kanahara

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 11, 2008
Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese populationNobuhisa Kanahara, Masaomi Iyo, Kenji Hashimoto
Psychiatric Genetics|January 3, 2020
A preliminary exome sequence in three patients with tardive dystoniaNobuhisa Kanahara, Yusuke Nakata, Masaomi Iyo
Psychiatric Genetics|September 17, 2020
Genetic association study detected misalignment in previous whole exome sequence: association study of ZNF806 and SART3 in tardive dystoniaNobuhisa Kanahara, Yusuke Nakata, Masaomi Iyo
Journal of Psychopharmacology (Oxford, England)|September 20, 2017
Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practiceYusuke Nakata, Nobuhisa Kanahara, Masaomi Iyo
Schizophrenia Research|March 14, 2016
Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia"Nobuhisa Kanahara, Hiroshi Kimura, Masaomi Iyo
International Journal of Molecular Sciences|December 24, 2015
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaYasunori Oda, Nobuhisa Kanahara, Masaomi Iyo
SAGE Open Medical Case Reports|March 4, 2017
Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia casesKatsumasa Muneoka, Nobuhisa Kanahara, Shou Kimura
Behavioural Brain Research|January 18, 2021
Rationale and neurobiological effects of treatment with antipsychotics in patients with chronic schizophrenia considering dopamine supersensitivityHiroshi Kimura, Nobuhisa Kanahara, Masaomi Iyo
Schizophrenia Research|February 14, 2013
Potential treatment strategy of risperidone in long-acting injectable form for schizophrenia with dopamine supersensitivity psychosisHiroshi Kimura, Nobuhisa Kanahara, Hiroyuki Watanabe, et al.
Annals of General Psychiatry|October 4, 2011
Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorderShigenori Tadokoro, Nobuhisa Kanahara, Shuichi Kikuchi, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 11, 2008
Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese populationNobuhisa Kanahara, Masaomi Iyo, Kenji Hashimoto
Psychiatric Genetics|January 3, 2020
A preliminary exome sequence in three patients with tardive dystoniaNobuhisa Kanahara, Yusuke Nakata, Masaomi Iyo
Psychiatric Genetics|September 17, 2020
Genetic association study detected misalignment in previous whole exome sequence: association study of ZNF806 and SART3 in tardive dystoniaNobuhisa Kanahara, Yusuke Nakata, Masaomi Iyo
Journal of Psychopharmacology (Oxford, England)|September 20, 2017
Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practiceYusuke Nakata, Nobuhisa Kanahara, Masaomi Iyo
Schizophrenia Research|March 14, 2016
Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia"Nobuhisa Kanahara, Hiroshi Kimura, Masaomi Iyo
International Journal of Molecular Sciences|December 24, 2015
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaYasunori Oda, Nobuhisa Kanahara, Masaomi Iyo
SAGE Open Medical Case Reports|March 4, 2017
Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia casesKatsumasa Muneoka, Nobuhisa Kanahara, Shou Kimura
Behavioural Brain Research|January 18, 2021
Rationale and neurobiological effects of treatment with antipsychotics in patients with chronic schizophrenia considering dopamine supersensitivityHiroshi Kimura, Nobuhisa Kanahara, Masaomi Iyo
Schizophrenia Research|February 14, 2013
Potential treatment strategy of risperidone in long-acting injectable form for schizophrenia with dopamine supersensitivity psychosisHiroshi Kimura, Nobuhisa Kanahara, Hiroyuki Watanabe, et al.
Annals of General Psychiatry|October 4, 2011
Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorderShigenori Tadokoro, Nobuhisa Kanahara, Shuichi Kikuchi, et al.
Pageof 12